Alkermes Says Experimental Drug Improved Wakefulness in Narcolepsy Trial

Alkermes Plc said an experimental drug improved wakefulness and reduced daytime sleepiness in people with a form of narcolepsy. In a statement, according to Bloomberg, the company said the findings suggest a promising new class of medicines could help more patients than originally expected.